Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy

Carcinogenesis

Volumn 31, Issue 3, 2010, Pages 446-454

  Zabirnyk, Olga ^a   Liu, Wei ^a   Khalil, Shadi ^a   Sharma, Anit ^a   Phang, James M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 OXOCHOLESTEROL; BECLIN 1; CELL NUCLEUS RECEPTOR; LIGHT CHAIN PROTEIN 3; MICROTUBULE ASSOCIATED PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE; UNCLASSIFIED DRUG; HYBRID PROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER RISK; CARCINOGENESIS; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; CARCINOMA; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME INDUCTION; FEMALE; GENETICS; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; RNA INTERFERENCE; TUMOR CELL LINE;

AUTOPHAGY; CARCINOMA; CELL LINE, TUMOR; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INDUCTION; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; NEOPLASM PROTEINS; PPAR GAMMA; PROLINE OXIDASE; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UP-REGULATION;

EID: 77950890848     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp299     Document Type: Article

References (52)

1. Suzuki, K. et al. (2004) Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study. Cancer Epidemiol. Biomarkers Prev., 13, 1781-1787.
2. Ross, J.S. et al. (2001) Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann. N.Y. Acad. Sci., 947, 271-292; discussion 292-293.
3. Furukawa, S. et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 114, 1752-1761.
4. Couillard, C. et al. (2005) Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J. Clin. Endocrinol. Metab., 90, 6454-6459.
5. Delimaris, I. et al. (2007) Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin. Biochem., 40, 1129-1134.
6. Ishigaki, Y. et al. (2008) Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation, 118, 75-83.
7. Zettler, M.E. et al. (2003) OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. Am. J. Physiol. Heart Circ. Physiol., 284, H644-H653.
8. Heinloth, A. et al. (2000) Stimulation of NADPH oxidase by oxidized lowdensity lipoprotein induces proliferation of human vascular endothelial cells. J. Am. Soc. Nephrol., 11, 1819-1825.
9. Esterbauer, H. et al. (1990) Possible mutagens derived from lipids and lipid precursors. Mutat. Res., 238, 223-233.
10. Zettler, M.E. et al. (2004) Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins. Arterioscler. Thromb. Vasc. Biol., 24, 727-732.
11. Maziere, C. et al. (2000) Oxidized LDL induces an oxidative stress and activates the tumor suppressor p53 in MRC5 human fibroblasts. Biochem. Biophys. Res. Commun., 276, 718-723.
12. Cheng, J. et al. (2007) Oxidized low-density lipoprotein stimulates p53-dependent activation of proapoptotic Bax leading to apoptosis of differentiated endothelial progenitor cells. Endocrinology, 148, 2085-2094.
13. Duerrschmidt, N. et al. (2006) Lectin-like oxidized low-density lipoprotein receptor-1-mediated autophagy in human granulosa cells as an alternative of programmed cell death. Endocrinology, 147, 3851-3860.
14. Martinet, W. et al. (2004) 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 24, 2296-2301.
15. Phang, J.M. et al. (2008) PPARgamma and proline oxidase in cancer. PPAR Res., 2008, 542694.
16. Nagy, L. et al. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell, 93, 229-240.
17. Pandhare, J. et al. (2006) Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. J. Biol. Chem., 281, 2044-2052.
18. Donald, S.P. et al. (2001) Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res., 61, 1810-1815.
19. Maxwell, S.A. et al. (2003) Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas. J. Biol. Chem., 278, 9784-9789.
20. Liu, Y. et al. (2005) MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis, 26, 1335-1342.
21. Liu, Y. et al. (2006) Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFATand MEK/ERK signaling. Oncogene, 25, 5640-5647.
22. Liu, Y. et al. (2009) Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res., 69, 6414-6422.
23. Pandhare, J. et al. (2009) Regulation and function of proline oxidase under nutrient stress. J. Cell Biochem., 107, 759-768.
24. Klionsky, D.J. (2007) Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell. Biol., 8,931-937.
25. Levine, B. et al. (2008) Autophagy in the pathogenesis of disease. Cell, 132, 27-42.
26. Mathew, R. et al. (2007) Role of autophagy in cancer. Nat. Rev. Cancer, 7, 961-967.
27. Kroemer, G. et al. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ., 16, 3-11.
28. Chen, H.W. et al. (2008) Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population. Cardiology, 110, 252-259.
29. Raijmakers, M.T. et al. (2004) Low plasma levels of oxidized low density lipoprotein in preeclampsia. Acta Obstet. Gynecol. Scand., 83, 1173-1177.
30. Klionsky, D.J. et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy, 4, 151-175.
31. Zabirnyk, O. et al. (2007) Nanoparticles as a novel class of autophagy activators. Autophagy, 3, 278-281.
32. Mueller, E. et al. (2000) Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc. Natl Acad. Sci. USA, 97, 10990-10995.
33. Brito, P.M. et al. (2008) Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis, 205, 126-134.
34. Nicklin, P. et al. (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell, 136, 521-534.
35. Cao, Y. et al. (2007) Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res., 17, 839-849.
36. Liang, X.H. et al. (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402, 672-676.
37. Karantza-Wadsworth, V. et al. (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev., 21, 1621-1635.
38. Phang, J.M. et al. (2008) The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids, 35, 681-690.
39. Sukhanov, S. et al. (2003) Global analysis of differentially expressed genes in oxidized LDL-treated human aortic smooth muscle cells. Biochem. Biophys. Res. Commun., 306, 443-449.
40. Chen, C.Y. et al. (2007) Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell. Life Sci., 80, 2469-2480.
41. Szweda, L.I. et al. (1993) Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J. Biol. Chem., 268, 3342-3347.
42. Phang, J.M. et al. (1978) Inhibition of proline oxidase by long-chain acyl coenzyme-A. Fed. Proc., 37, 1480.
43. Brown, A.J. et al. (1999) Oxysterols and atherosclerosis. Atherosclerosis, 142, 1-28.
44. 2+ and inhibited by the calcium channel blocker nifedipine. Metabolism, 56, 357-362.
45. Rao, M.L. et al. (1999) Induction of apoptosis and necrosis in human neuroblastoma cells by cholesterol oxides. Ann. N.Y. Acad. Sci., 893, 379-381.
46. Kim, K.Y. et al. (2007) Apoptotic action of peroxisome proliferatoractivated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Mol. Pharmacol., 72, 674-685.
47. Overholtzer, M. et al. (2007) A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell, 131, 966-979.
48. Seleverstov, O. et al. (2009) Semiconductor nanocrystals in autophagy research: methodology improvement at nanosized scale. Methods Enzymol., 452, 277-296.
49. Beachy, P.A. et al. (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature, 432, 324-331.
50. Polyak, K. et al. (1997) A model for p53-induced apoptosis. Nature, 389, 300-305.
51. White, T.A. et al. (2007) Structure and kinetics of monofunctional proline dehydrogenase from Thermus thermophilus. J. Biol. Chem., 282, 14316-14327.
52. Chen, Y. et al. (2009) Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ., 16, 1040-1052.